selected publications
- Editorial: Diabetic kidney disease: routes to drug development, pharmacology and underlying molecular mechanisms. Frontiers in pharmacology. 2023 Editorial Article GET IT
- Autophagy and mitophagy: physiological implications in kidney inflammation and diseases. American journal of physiology. Renal physiology. 2023 Review GET IT
-
Iron therapy mitigates chronic kidney disease progression by regulating intracellular iron status of kidney macrophages.
JCI insight.
2023
Academic Article
GET IT
Times cited: 10 -
Conditional deletion of myeloid-specific mitofusin 2 but not mitofusin 1 promotes kidney fibrosis.
Kidney international.
2022
Academic Article
GET IT
Times cited: 16 -
Mitochondrial dysfunction in kidney injury, inflammation, and disease: Potential therapeutic approaches.
Kidney research and clinical practice.
2020
Review
GET IT
Times cited: 91 -
Carbonyl iron and iron dextran therapies cause adverse effects on bone health in juveniles with chronic kidney disease.
Kidney international.
2020
Academic Article
GET IT
Times cited: 9 -
Autophagy in kidney disease: Advances and therapeutic potential.
Progress in molecular biology and translational science.
2020
Review
GET IT
Times cited: 23 -
Mitophagy-dependent macrophage reprogramming protects against kidney fibrosis.
JCI insight.
2019
Academic Article
GET IT
Times cited: 96 -
The Emerging Role of Mitophagy in Kidney Diseases.
Journal of life sciences (Westlake Village, Calif.).
2019
Academic Article
GET IT
Times cited: 49 -
Mitofusins regulate lipid metabolism to mediate the development of lung fibrosis.
Nature communications.
2019
Academic Article
GET IT
Times cited: 92 -
C-Terminal Fibroblast Growth Factor-23 Levels in Non-Nutritional Hypophosphatemic Rickets.
Indian journal of pediatrics.
2019
Academic Article
GET IT
Times cited: 4 -
Interleukin-6 Contributes to the Development of Anemia in Juvenile CKD.
Kidney international reports.
2018
Academic Article
GET IT
Times cited: 34 -
Beclin-1 regulates cigarette smoke-induced kidney injury in a murine model of chronic obstructive pulmonary disease.
JCI insight.
2018
Academic Article
GET IT
Times cited: 16 -
Rituximab modulates T- and B-lymphocyte subsets and urinary CD80 excretion in patients with steroid-dependent nephrotic syndrome.
Pediatric research.
2018
Academic Article
GET IT
Times cited: 40 -
Autophagy: A Lysosome-Dependent Process with Implications in Cellular Redox Homeostasis and Human Disease.
Antioxidants & redox signaling.
2018
Review
GET IT
Times cited: 58 -
Mutations in membrane cofactor protein (CD46) gene in Indian children with hemolytic uremic syndrome.
Clinical kidney journal.
2017
Academic Article
GET IT
Times cited: 8 -
Incomplete penetrance of CD46 mutation causing familial atypical hemolytic uremic syndrome.
2015
GET IT
Times cited: 7 -
Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2014
Academic Article
GET IT
Times cited: 60 -
Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children.
Kidney international.
2014
Academic Article
GET IT
Times cited: 88 -
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children.
Kidney international.
2013
Academic Article
GET IT
Times cited: 141 - Diabetic Kidney Disease: Routes to drug development, pharmacology and underlying molecular mechanisms. Book